Imunoexpression of Ki-67 and p53 in Rectal Cancer Tissue After Treatment with Neoadjuvant Chemoradiation

ISSN： 1941-6628

Source： Journal of Gastrointestinal Cancer, Vol.42, Iss.1, 2011-03, pp. : 34-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interval Between Neoadjuvant Chemoradiation and Surgery for the Management of Rectal Cancer

By Huerta Sergio

Journal of Gastrointestinal Surgery, Vol. 15, Iss. 7, 2011-07 ,pp. : 1292-1292

Springer Publishing Company

Access to resources Recommend Favorite

Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T₂ weighted and PET/CT imaging

By SONG I KIM S H LEE S J CHOI J Y KIM M J RHIM H

British Journal of Radiology, Vol. 85, Iss. 1013, 2012-05 ,pp. : 577-586

British Institute of Radiology

Access to resources Recommend Favorite

Response to Letter to the Editor: Neoadjuvant Therapy for Rectal Cancer: The Impact of Longer Interval Between Chemoradiation and Surgery

By Campos-Lobato Luiz

Journal of Gastrointestinal Surgery, Vol. 15, Iss. 7, 2011-07 ,pp. : 1293-1293

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Radiochemotherapy for Rectal Cancer

Digestive Diseases, Vol. 25, Iss. 1, 2007-03 ,pp. : 56-66

Karger

Access to resources Recommend Favorite

Complete Response after Neoadjuvant Therapy in Rectal Cancer: To Operate or Not to Operate?

Digestive Diseases, Vol. 30, Iss. 2, 2012-11 ,pp. : 109-117

Karger

Access to resources Recommend Favorite